Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. X4 Pharmaceuticals Inc shares valued at $14,654 were purchased by Baldry Mark on May 17 ’24. At $0.68 per share, Baldry Mark acquired 21,646 shares. The insider’s holdings grew to 115,769 shares worth approximately $43992.22 following the completion of this transaction.
Also, Baldry Mark purchased 13,404 shares, netting a total of over 4,598 in proceeds. Following the buying of shares at $0.34 each, the insider now holds 129,173 shares.
Before that, Ragan Paula had sold 76,473 shares from its account. In a trade valued at $34,719, the President and CEO traded X4 Pharmaceuticals Inc shares for $0.45 each. Upon closing the transaction, the insider’s holdings decreased to 76,473 shares, worth approximately $0.41 million.
As published in a research note from B. Riley Securities on December 12, 2023, X4 Pharmaceuticals Inc [XFOR] has been rated down from a Buy to a Neutral and the price target has been revised to $1 from $3. As of December 22, 2022, Cantor Fitzgerald has initiated its “an Overweight” rating for XFOR. Earlier on December 12, 2022, Piper Sandler initiated its rating. Their recommendation was “an Overweight” for XFOR stock.
Analyzing XFOR Stock Performance
During the last five days, there has been a surge of approximately 1.52%. Over the course of the year, X4 Pharmaceuticals Inc shares have dropped approximately -48.87%. Shares of the company reached a 52-week high of $0.8147 on 01/02/25 and a 52-week low of $0.3400 on 03/04/25. A 50-day SMA is recorded $0.5478, while a 200-day SMA reached $0.6445.
Support And Resistance Levels for X4 Pharmaceuticals Inc (XFOR)
According to the 24-hour chart, there is a support level at 0.3634, which, if violated, would cause prices to drop to 0.3517. In the upper region, resistance lies at 0.3834. The next price resistance is at 0.3917. RSI (Relative Strength Index) is 36.59 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.0576, which suggests the price will decrease in the coming days. Percent R is at 82.71%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.